Bradley Scott

10% OwnerXTL BIOPHARMACEUTICALS LTD (XTLB) · full profile →Form 4 · filed Mar 19, 2008
Net Buying
Open-Market Buys
$7.8M
Open-Market Sells
$0
Net Open-Market Flow
$7.8M
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 7, 2008Buy(P)940K$3.74$3.5M52.5M
Mar 7, 2008Buy(P)9K$3.65$33K2.7M
Mar 7, 2008Buy(P)60K$3.74$224K2.8M
Mar 7, 2008Buy(P)141K$3.65$516K52.6M
Mar 6, 2008Buy(P)616K$3.86$2.4M51.3M
Mar 6, 2008Buy(P)244K$3.73$912K51.6M
Mar 6, 2008Buy(P)39K$3.86$152K2.7M
Mar 6, 2008Buy(P)16K$3.73$58K2.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000909012-08-000446) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about XTLB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000909012-08-000446"
Ask your agent
Use Arkolith to summarize insider buying and selling at XTL BIOPHARMACEUTICALS LTD
over the last 90 days and cite the filings.